Hovig E - Search Results

1

Results of multigene panel testing in familial cancer cases without genetic cause demonstrated by single gene testing.

Dominguez-Valentin M, Nakken S, Tubeuf H, Vodak D, Ekstrøm PO, Nissen AM, Morak M, Holinski-Feder E, Holth A, Capella G, Davidson B, Evans DG, Martins A, Møller P, Hovig E. Dominguez-Valentin M, et al. Among authors: hovig e. Sci Rep. 2019 Dec 6;9(1):18555. doi: 10.1038/s41598-019-54517-z. Sci Rep. 2019. PMID: 31811167 Free PMC article.

2

A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing.

Dørum A, Møller P, Kamsteeg EJ, Scheffer H, Burton M, Heimdal KR, Maehle LO, Hovig E, Tropé CG, van der Hout AH, van der Meulen MA, Buys CH, te Meerman GJ. Dørum A, et al. Among authors: hovig e. Eur J Cancer. 1997 Dec;33(14):2390-2. doi: 10.1016/s0959-8049(97)00328-6. Eur J Cancer. 1997. PMID: 9616287

3

Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancer.

Dørum A, Heimdal K, Hovig E, Inganäs M, Møller P. Dørum A, et al. Among authors: hovig e. Am J Hum Genet. 1999 Sep;65(3):671-9. doi: 10.1086/302530. Am J Hum Genet. 1999. PMID: 10441573 Free PMC article.

4

Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA.

Dørum A, Hovig E, Tropé C, Inganas M, Møller P. Dørum A, et al. Among authors: hovig e. Eur J Cancer. 1999 May;35(5):779-81. doi: 10.1016/s0959-8049(99)00050-7. Eur J Cancer. 1999. PMID: 10505039

5

BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations.

Borg A, Dørum A, Heimdal K, Maehle L, Hovig E, Møller P. Borg A, et al. Among authors: hovig e. Dis Markers. 1999 Oct;15(1-3):79-84. doi: 10.1155/1999/278269. Dis Markers. 1999. PMID: 10595257 Free PMC article.

6

The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series.

Møller P, Borg A, Heimdal K, Apold J, Vallon-Christersson J, Hovig E, Maehle L; Norwegian Inherited Breast Cancer Group; Norwegian Inherited Ovarian Cancer Group. Møller P, et al. Among authors: hovig e. Eur J Cancer. 2001 May;37(8):1027-32. doi: 10.1016/s0959-8049(01)00075-2. Eur J Cancer. 2001. PMID: 11334729

7

Genetic epidemiology of BRCA1 mutations in Norway.

Møller P, Heimdal K, Apold J, Fredriksen A, Borg A, Hovig E, Hagen A, Hagen B, Pedersen JC, Maehle L; Norwegian Inherited Breast Cancer Group; Norwegian Inherited Ovarian Cancer Group. Møller P, et al. Among authors: hovig e. Eur J Cancer. 2001 Dec;37(18):2428-34. doi: 10.1016/s0959-8049(01)00299-4. Eur J Cancer. 2001. PMID: 11720839

8

Determination of hereditary mutations in the BRCA1 gene using archived serum samples and capillary electrophoresis.

Ekstrøm PO, Bjørge T, Dørum A, Longva AS, Heintz KM, Warren DJ, Hansen S, Gislefoss RE, Hovig E. Ekstrøm PO, et al. Among authors: hovig e. Anal Chem. 2004 Aug 1;76(15):4406-9. doi: 10.1021/ac049788k. Anal Chem. 2004. PMID: 15283579

9

Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriers.

Møller P, Hagen AI, Apold J, Maehle L, Clark N, Fiane B, Løvslett K, Hovig E, Vabø A. Møller P, et al. Among authors: hovig e. Eur J Cancer. 2007 Jul;43(11):1713-7. doi: 10.1016/j.ejca.2007.04.023. Epub 2007 Jun 15. Eur J Cancer. 2007. PMID: 17574839

10

Large-scale inference of the point mutational spectrum in human segmental duplications.

Nakken S, Rødland EA, Rognes T, Hovig E. Nakken S, et al. Among authors: hovig e. BMC Genomics. 2009 Jan 22;10:43. doi: 10.1186/1471-2164-10-43. BMC Genomics. 2009. PMID: 19161616 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

256 results

Search Page